Singapore markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
3.7600-0.1400 (-3.59%)
As of 02:53PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-28,221
-28,221
-18,490
-22,990
-3,997
Depreciation & amortisation
155.527
155.527
147.894
111.529
116.809
Stock-based compensation
1,412
1,412
1,434
4,215
228.68
Change in working capital
5,352
5,352
1,515
-211.431
1,583
Accounts payable
577.908
577.908
1,324
-
-
Other working capital
-20,757
-20,757
-14,631
-15,073
-403.784
Other non-cash items
586.004
586.004
659.951
3,409
1,797
Net cash provided by operating activities
-20,684
-20,684
-14,395
-14,642
-403.784
Cash flows from investing activities
Investments in property, plant and equipment
-73.377
-73.377
-235.55
-431.673
-
Purchases of investments
0
0
-3,272
-9,000
-
Sales/maturities of investments
0
0
13,342
0
-
Other investing activities
-
-
-
-5,018
-56.687
Net cash used for investing activities
-73.377
-73.377
9,834
-14,450
24.618
Cash flows from financing activities
Debt repayment
-144.437
-144.437
-142.268
-586.426
-1,101
Common stock issued
15,887
15,887
10,637
37,833
0
Other financing activities
-
-
-
-
-235.949
Net cash used provided by (used for) financing activities
21,014
21,014
10,801
49,915
-626.644
Net change in cash
256.97
256.97
6,240
20,824
-1,006
Cash at beginning of period
18,263
18,263
12,531
150.126
1,156
Cash at end of period
19,342
19,342
18,263
20,892
150.126
Free cash flow
Operating cash flow
-20,684
-20,684
-14,395
-14,642
-403.784
Capital expenditure
-73.377
-73.377
-235.55
-431.673
-
Free cash flow
-20,757
-20,757
-14,631
-15,073
-403.784